UNSPSC 51343105: Emtricitabine

This classification denotes a reverse transcriptase inhibitor and pyrimidine antagonist with the molecular formula C8H10FN3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G70B4ETF4S, chemically known as 5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine but generally known as emtricitabine, which bears US NIH Compound Identifier 60877. European Medicines Agency schedules Emtricitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01882MIG.

UNSPSC 51343105 Emtricitabine (Commodity) does not align with the recent state and local procurement activity tagged under this code. The two most recent opportunities show no purchase of Emtricitabine, the antiretroviral pharmaceutical specified by the code. Instead, the Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride—both antibiotics unrelated to HIV treatment—with a total contract value of $2,999,999.11 over three years. Seminole County, Florida issued an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, a public-health emergency-response procurement. Neither opportunity involves the antiretroviral class of drugs that this commodity code nominally covers. The mismatch suggests either a tagging error in the underlying system or a fundamental divergence between the code's scope and actual procurement practice under it.

State and local government procurement activity under this code shows little relevant current opportunity. If Emtricitabine procurement is occurring at the state or local level, it is not appearing in recent solicitations or awards, or is being coded under different UNSPSC categories. Business development professionals should verify whether this code represents actual procurement demand in their target markets before pursuing opportunities tagged under it.